Michael A Arnold

Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies

R. Venkatramani, S. Hiniker, Amira Qumseya, 2023, Pediatric Blood & Cancer.

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.

D. Hawkins, E. Rudzinski, R. Venkatramani, 2024, The Lancet. Oncology.